Anti-GOLT1A monoclonal antibody

Pre-made anti-GOLT1A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GOLT1A/GOLT1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0920-Ab-1/ GM-Tg-hg-IP0920-Ab-2Anti-Human GOLT1A monoclonal antibodyHuman
GM-Tg-rg-IP0920-Ab-1/ GM-Tg-rg-IP0920-Ab-2Anti-Rat GOLT1A monoclonal antibodyRat
GM-Tg-mg-IP0920-Ab-1/ GM-Tg-mg-IP0920-Ab-2Anti-Mouse GOLT1A monoclonal antibodyMouse
GM-Tg-cynog-IP0920-Ab-1/ GM-Tg-cynog-IP0920-Ab-2Anti-Cynomolgus/ Rhesus macaque GOLT1A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0920-Ab-1/ GM-Tg-felg-IP0920-Ab-2Anti-Feline GOLT1A monoclonal antibodyFeline
GM-Tg-cang-IP0920-Ab-1/ GM-Tg-cang-IP0920-Ab-2Anti-Canine GOLT1A monoclonal antibodyCanine
GM-Tg-bovg-IP0920-Ab-1/ GM-Tg-bovg-IP0920-Ab-2Anti-Bovine GOLT1A monoclonal antibodyBovine
GM-Tg-equg-IP0920-Ab-1/ GM-Tg-equg-IP0920-Ab-2Anti-Equine GOLT1A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0920-Ab-1/ GM-Tg-hg-IP0920-Ab-2; GM-Tg-rg-IP0920-Ab-1/ GM-Tg-rg-IP0920-Ab-2;
GM-Tg-mg-IP0920-Ab-1/ GM-Tg-mg-IP0920-Ab-2; GM-Tg-cynog-IP0920-Ab-1/ GM-Tg-cynog-IP0920-Ab-2;
GM-Tg-felg-IP0920-Ab-1/ GM-Tg-felg-IP0920-Ab-2; GM-Tg-cang-IP0920-Ab-1/ GM-Tg-cang-IP0920-Ab-2;
GM-Tg-bovg-IP0920-Ab-1/ GM-Tg-bovg-IP0920-Ab-2; GM-Tg-equg-IP0920-Ab-1/ GM-Tg-equg-IP0920-Ab-2
Products NameAnti-GOLT1A monoclonal antibody
Formatmab
Target NameGOLT1A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GOLT1A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0920-Ag-1Recombinant multi-species GOT1A/ GOLT1A/ CGI-141 protein


    Target information

    Target IDGM-IP0920
    Target NameGOLT1A
    Gene ID127845,68338,498230,700305,606914,101081948,508464,100054345
    Gene Symbol and Synonyms0610012C01Rik,CGI-141,GOLT1A,GOT1,hGOT1b,HMFN1187,Kiss1,metastatin,RGD1566310,YMR292W
    Uniprot AccessionQ6ZVE7,Q2NKV8
    Uniprot Entry NameGOT1A_HUMAN,GOT1A_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174567
    Target ClassificationN/A

    The target: GOLT1A, gene name: GOLT1A, also named as CGI-141, GOT1, HMFN1187, YMR292W, hGOT1b. Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Located in Golgi apparatus subcompartment; endoplasmic reticulum; and nuclear envelope. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.